HOXA11 and laryngeal squamous cell carcinoma: For example, HOXA11-AS can act as an oncogene in non-small cell lung cancer (NSCLC), hepatocellular carcinoma (HCC), glioma, breast cancer (BC), gastric cancer (GC), kidney cancer (RC), uveal melanoma (UM), laryngeal squamous cell carcinoma (LSCC), cervical cancer (CC), esophageal squamous cell carcinoma (ESCC), and osteosarcoma [16, 41–47].